Get a Sample
Schedule a Meeting
Get a Sample
Table Of Content
March 2025
The global cyclic olefin polymer market size is calculated at USD 1.24 billion in 2025 and is forecasted to reach around USD 2.19 billion by 2034, accelerating at a CAGR of 6.55% from 2025 to 2034. The North America market size surpassed USD 609.00 million in 2024 and is expanding at a CAGR of 6.66% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global cyclic olefin polymer market size accounted for USD 1.16 billion in 2024 and is predicted to increase from USD 1.24 billion in 2025 to approximately USD 2.19 billion by 2034, expanding at a CAGR of 6.55% from 2025 to 2034. The market growth is attributed to rising adoption of high-purity, chemically inert polymers in advanced medical, diagnostic, and optical applications across regulated industries.
Artificial intelligence has sized up the development, production and application of cyclic olefin polymers (COPs) significantly. The design of high-performance COPs with niche applications, such as diagnostics and pharmaceutical packaging. AI systems also can be used in the field of manufacturing, where they continuously adjust process parameters to produce products in a consistent way, minimize defects, and decrease operating costs. Furthermore, the machine learning algorithms are also used in companies to predict the demand trend and optimal logistic administration of products to ensure effective supply chain functioning.
The U.S. cyclic olefin polymer market size was exhibited at USD 426.30 million in 2024 and is projected to be worth around USD 818.29 million by 2034, growing at a CAGR of 6.74% from 2025 to 2034.
North America led the cyclic olefin polymer market, capturing the largest revenue share in 2024
North America led the cyclic olefin polymer market, capturing the largest revenue share in 2024, due to their fastest rate stimulated by a sophisticated pharmaceutical and electronics industry and a wide regulatory background. The USFDA Food Contact Notification 1104 TOPAS 1104 COC plus the USP 1104 Class VI/ISO 10993 supported the use of cyclic olefin polymer. Optical performance NIST and IEC standards allow and stress on COP/COC usage in photonic sensors and high resolution lenses. Diagnosis manufacturing trends are now including onshoring, which has been speeded up with post-COVID development. This creates a request in COP based cuvettes and test kits.
In 2024, the FDA approved high number of new companion diagnostic devices, which opened more potential over COP-based platforms in regulated laboratories. The licenses have been issued to manufacturers of rapid test kits with sterilizable polymer housing by Health Canada, and this is one of the indicators of how COP complies with ISO 11607 and ISO 10993. The NIST invested CHIPS Act polymer metrology programs to help test material of photonics and microelectronics between June and September 2024. Moreover, the low-birefringence thermoplastics used to make optical components and made direct references to formulations of cyclic olefins used in making lenses, thus further propelling the market in this region.
(Source: https://www.nist.gov)
Asia Pacific Cyclic Olefin Polymer Market Trends
Asia Pacific is anticipated to grow at the fastest rate in the market during the forecast period, owing to the increasing level of usage of COP/COC-based vials and prefillable devices. The COP materials applied by Japan manufacturers with the help of Ministry of Health, Labour and Welfare (MHLW). Further they being controlled with PMDA are built on ISO 10993 to support diagnostic and injectable packaging, which strengthened the uptake of the region. The region has many manufacturers focusing on quality and traceability as required by the ASEAN-Japan health meetings that further invest in COP- compatible production lines.
China and Japan are key growth enabled poles in the Asia Pacific region that export healthcare and electronics applications of cyclic olefins polymers. Local production of medical grade plastics was a focus of state sponsored efforts aimed at the Made in China 2025 strategy that was having the effect of promoting upstream investments into cyclic olefin processing plants. Electronics manufacturers of Japan especially those around Osaka and Tokyo-tech-corridors were showing an increasing use of COP into optical sensors. Additionally, the growing adoption of COC/COP-based microfluidics and diagnostic cartridges is expected to boost the market in the coming years.
(Source: https://orcasia.org)
What to Expect from Europe’s Cyclic Olefin Polymer Market?
The Europe region is expected to hold a notable revenue share of the market, as strong stringent regulatory codes and the rise in demand of the materials on account of sustainability and high performance materials. In 2024, the European Pharmacopoeia Commission formally recognised monographs Ph. Eur. 3.1.16 and 3.1.17, making COP and COC compliant substances with primary packaging of pharmaceuticals. Such insertions standardized using material in the EU applications like prefillable syringes, vials and cartridge diagnostics. Furthermore, the intensive investments in research under EU Horizon initiatives, make Europe region encouraging regulatory-proofed and circular ready introduction of cyclic olefin polymers to life science and high tech applications.
(Source: https://www.edqm.eu)
Cyclic Olefin Polymers (COPs) are a class of amorphous polymers synthesized through the copolymerization of cyclic olefins (such as norbornene) with other olefins like ethylene. These polymers exhibit exceptional transparency, low moisture absorption, high thermal resistance, excellent biocompatibility, and chemical inertness, making them suitable for a wide range of applications in pharmaceutical packaging, optical components, medical devices, and electronics.
The intense demand of high end drug delivery packaging and diagnostic packaging is likely to propel the market as the pharmaceutical firms are demanding more chemically inert and high-clarity materials. Applications using these polymers include prefilled syringes, diagnostic cuvettes and microfluidic systems and semiconductor lens systems. The U.S. FDA cleared COC materials such as TOPAS (supplied by Cytec in the U.S.) by Food Contact Notification 1104, to provide regulatory harmonization when used in parenteral packaging, lab consumables and other applications. Furthermore, the increased adoption of COP in LiDAR, smartphone optical and wearable sensors is also expected to drive the further fuels demand for these type of polymers.
| Report Coverage | Details |
| Market Size by 2034 | USD 2.19 Billion |
| Market Size in 2025 | USD 1.24 Billion |
| Market Size in 2024 | USD 1.16 Billion |
| Market Growth Rate from 2025 to 2034 | CAGR of 6.55% |
| Dominating Region | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
| Segments Covered | Type, Application, End User and Region |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
How Is the Shift Toward High-Barrier Packaging Transforming the Cyclic Olefin Polymer Market?
Increasing demand for high-performance packaging materials is expected to accelerate the cyclic olefin polymers market growth. These polymers bring together purity, optical clarity, and superior barrier performance and usefully be applied to syringes and vials and diagnostic containers, particularly in a biologic and sensitive product form. The FDA database notes several drug-device combination products cleared with cyclic olefin copolymer (COC) or polymer (COP) components have been proven to be safe and compatible in terms of regulatory clearance at 21 CFR 177.1520 and USP <661>. The selected COP vials used in the EMA licensed biologic drug, Imlygic 12, a herpesvirus-based therapy, recently approved by the European Medical Agency (EMA) in its public assessment report.
They are specifically chosen to mitigate against adsorption risks and leaching, two major structural risks in advanced biologics. The recyclability and REACH compliance of several grades of COP has been confirmed by RecyClass and the European Chemicals Agency (ECHA), which help in achieving the sustainability objectives and gaining access to Europe. Furthermore, the rising number of approved biologics that rose to 55 in 2018 and reached more than 130 at the end of 2024 as per FDA, Center for Drug Evaluation and Research (CDER), thus further fuelling the market.
Limited recyclability and end-of-life concerns impede wider application of cyclic olefin polymers
Recyclability and end-of-life concerns of cyclic olefin polymer is expected to hinder the market growth. In spite of having performance advantages, the chemical composition of COP does not allow it to be integrated with traditional mechanical recycling. In contrast to PET, or HDPE, COP be processed in specialized sorts and handled, which is hardly present at municipal waste systems. The use of circular materials is gaining more and more attention through regulatory frameworks, including those informed by the European Chemicals Agency (ECHA) Likewise, an increasing number of regulatory frameworks promote extended producer responsibility (EPR) policies. Furthermore, the COP drawbacks unless manufacturers create solutions of closed-loop recycling or certified bio-degradable variants, both of which are at the infancy of development.
How Are Material Innovations and R&D Investments Accelerating Growth in the Cyclic Olefin Polymer Market?
Rising investments in advanced material research and innovation are likely to create immense opportunities for the players competing in the market. Major research centers, such as NIST are investing in the mapping of polyolefin architectures and modelling processing behaviour. They are aiming of enhancing characterisation and recyclability with the focus on materials.
These novel polymerization methods, such as living coordination chain transfer polymerization (LCCTP) that allow manufacturers to make narrow-distribution, high-precision polyolefin grades suited to COP use. Improvements related to injection molding, such as nitrogen hopper purging, temperature precision near Tg+10 and the design of nozzles, are the results of molding principles recommended by ISO. Furthermore, this concurrent R&D activity enables processing by injection molding, blow molding, and the newly emerging 3D printing is expected to facilitate the growth of the cyclic olefin polymer market.
Why Did the Cyclic Olefin Copolymer (COC) Segment Capture largest share of the Market Share in 2024?
Cyclic olefin copolymer (COC) segment dominated the cyclic olefin polymer market in 2024 accounting for 68.3% of total market share, due to the its good moisture barrier properties, which are important features of optical lenses, medical syringes or diagnostics constituents. In the glass like injection and injection blow molding precision industries, COC low birefringence and dimension stability as QAISO and ASTM standard qualities. They allowes long term high volume consistent injection and injection blow mold. Food Contact Notification no. 1104 issued by the FDA certified that TOPASGuard TOPAS COC was biocompatible and safe per USP. Furthermore, the adoption of COC was backed by regulatory approvals by EMA and Health Canada thus strengthening its market hegemony in healthcare.
The cyclic olefin polymer (COP) segment is projected to grow at the fastest rate in the forecast years. COP is an exemplary material when it comes to stability of refractive index over the UV-NIR spectra, and extremely low birefringence, which has been proven by NIST and ASTM optical measurement systems. The high temperature resistance (up to ~140 C) and chemical resistance allow this high grade of COP polymer to be deployed even in applications requiring such elevated capability.
Investment in the grades of COP to meet the precision-optics needs is helping with the quick market growth and increasing adoption in specialized industries. Additionally, the growing developments indicate a broader use of the COP in the medtech, life sciences and precision manufacturing industries, thus boosting the segment in the coming years.
What Drove the Pharmaceutical and Medical Segment to Dominate the Market in 2024?
Pharmaceutical and Medical segment dominated the market accounting for61.4% market share, due to the increased advanced healthcare technology and precision diagnostics. COP is UV-NIR refractively stable and has ultra-low birefringence, both characteristics recorded in both NIST and ASTM optical metrology reports. Thus adapted to microfluidic chips, imaged-based devices and disposable optics. Japan The Pharmaceuticals and Medical Devices Agency (PMDA) of Japan has also approved COP-based diagnostic cartridges based on successful sterilization with gamma and EtO sterilization processes to be used as IVD. Furthermore, the EMA and FDA regulatory focus on extractables/leachables have resulted in the switch by healthcare producers out of legacy plastics into COP.
Why Did the Healthcare & Life Sciences Segment Dominate the Cyclic Olefin Polymer Market Share in 2024?
Healthcare & life sciences segment dominated the cyclic olefin polymer market in 2024 with 64.7% of total market share, due to the its attractive optical transparencies and superb moisture-barrier properties, and its ultra-low extractables. TOPAS COC has been qualified by the U.S FDA under Food Contact Notification process 1104 to be used as food contact and medical materials. COP/COC was cited in EMA master files by combination products, used to support regulatory filings of pre-filled syringes, blister packs and point-of-care devices.
COC was among the recommended materials in aqueous and biologic containers because of exhibiting inert properties and good moisture barrier. ISO D7436 and ISO 11607 certification gives assurance of performance by COC in sterile barrier packages, and ASTM D6705 gives the optical and mechanical specifications. This division was boosted by an increase in number of approvals of biologics-more than 130 worldwide in 2024, as indicated by the EMA records-a factor that pushed up the demand of packaging that is contamination-free and preservative-resistant. Additionally, the solid support and trade-standard conversion further boosts the market in this sector.
Electronic & semiconductor industry segment is observed to grow rapidly in the cyclic olefin polymer market in the coming years, owing to the increasing product demand of superior optical and insulating polymers. High refractive index and uniformity, combined with low birefringence, are also in compliance with NIST and IEC standards in the precision optics and photonic components areas. At the wafer-level packaging and lens arrays COP/COC is more and more commonly used by semiconductor manufacturers given that the metal ion contribution cannot exceed the level of ppm depending on the impurity aline with the BIS and Health Canada.
A 2022 Wiley review highlights cyclic olefin copolymer as a primary material for microfluidic platforms, citing its low water absorption, electrical insulation, and chemical resistance. The use of automotive lidar sensors backed by the capability of COP within residential, commercial and industrial thermal cycling. The tolerance range of the UV environment to IEC 60825 standard should place a faster adoption of materials. Furthermore, since miniaturisation of devices and the need to achieve high resolution imaging gain grounds in the smartphones and autonomous systems, this segment facilitating the utilization of these polymers.
(Source: https://onlinelibrary.wiley.com)
By Type
By Application
By End User
By Region
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
March 2025
January 2025
May 2025
May 2025